Used by millions of patients worldwide, the KwikPen® for single-patient use provides patients with a new option to receive Zepbound® Zepbound patients can access all doses in either multi-dose KwikPen ...
The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.
Please provide your email address to receive an email when new articles are posted on . The Zepbound KwikPen allows patients to receive four doses of the drug in a single pen device. According to Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results